You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Teva Womens Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for TEVA WOMENS, and what generic and branded alternatives to TEVA WOMENS drugs are available?

TEVA WOMENS has eight approved drugs.



Summary for Teva Womens
US Patents:0
Tradenames:14
Ingredients:8
NDAs:8

Drugs and US Patents for Teva Womens

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Womens ANTABUSE disulfiram TABLET;ORAL 007883-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up
Teva Womens ADDERALL 7.5 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate TABLET;ORAL 011522-011 Aug 31, 2000 DISCN Yes No ⤷  Sign Up ⤷  Sign Up
Teva Womens ADDERALL 20 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate TABLET;ORAL 011522-008 Feb 13, 1996 DISCN Yes No ⤷  Sign Up ⤷  Sign Up
Teva Womens ADDERALL 5 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate TABLET;ORAL 011522-009 May 12, 1997 DISCN Yes No ⤷  Sign Up ⤷  Sign Up
Teva Womens DIAMOX acetazolamide sodium INJECTABLE;INJECTION 009388-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Teva Womens

Paragraph IV (Patent) Challenges for TEVA WOMENS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 5 mg, 10 mg, 20 mg, 30 mg ➤ Subscribe 2009-11-18
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.